Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 Diabetes Res Clin Pract
That said, we know that it isn't right for everyone, and we'll be quick to point out when a competitor's product could be a better choice for you
Higher cellular NAD+ was reported in preclinical work
The National Institute of Diabetes and Digestive and Kidney Diseases provides clinical context on how GLP-1 medications affect appetite regulation and energy balance
These findings imply that the BM reduction effect of GTE supplementation may depend on participants oxidative and inflammatory status, as obesity has been characterised by a low-grade inflammatory state and oxidative stress status (Reference Pereira and Alvarez-Leite109)